ATO depreciation rates for pharmaceutical manufacturing assets in the Manufacturing industry, under Income Tax (Effective Life of Depreciating Assets) Determination 2025 (LI 2025/20).
7 assets listed.
| Asset | Effective life | Prime cost rate | Diminishing value rate | Applicable from |
|---|---|---|---|---|
| Automated (including bottle rinsers/washers, cappers, capsule applicators and foilers) | 15 years | 6.67% | 13.33% | 1 July 2025 |
| Bottle and vial inverters and blowers | 10 years | 10.00% | 20.00% | 1 July 2025 |
| Bottle and vial unscramblers | 10 years | 10.00% | 20.00% | 1 July 2025 |
| Tablet and capsule coating machines, coating drums and coating pans | 12 years | 8.33% | 16.67% | 1 July 2025 |
| Tablet dedusters | 10 years | 10.00% | 20.00% | 1 July 2025 |
| Tablet/capsule fillers, feeders and counters | 10 years | 10.00% | 20.00% | 1 July 2025 |
| Weighing scales Scientific medical and pharmaceutical research assets | 10 years | 10.00% | 20.00% | 1 July 2025 |
The effective lives shown above are determined by the Commissioner of Taxation under section 40-100 of the Income Tax Assessment Act 1997. The diminishing value rate equals 200% ÷ effective life (for assets acquired on or after 10 May 2006). The prime cost rate equals 100% ÷ effective life. You may alternatively self-assess effective life — see the ATO website for guidance.